What can we learn from the three megatrials using anticoagulants in severe sepsis?
Iba
Toshiaki
T
Department of Surgery, Juntendo Urayasu Hospital, Juntendo University School of Medicine, Chiba 279-0021, Japan. iba-jun@umin.ac.jp
Kidokoro
Akio
A
D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018805:Sepsis / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index
D000925:Anticoagulants; D006493:Heparin